Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer: a multicentric phase II study
1998

Biochemical Modulation of 5-Fluorouracil in Colorectal Cancer

Sample size: 56 publication Evidence: moderate

Author Information

Author(s): C Aschele, A Guglielmi, GL Frassineti, C Milandri, D Amadori, R Labianca, M Vinci, L Tixi, C Caroti, E Ciferri, E Verdi, R Rosso, A Sobrero

Primary Institution: Istituto Nazionale per la Ricerca sul Cancro

Hypothesis

Can the addition of natural beta-interferon enhance the efficacy of a regimen alternating bolus and continuous infusion of 5-fluorouracil in advanced colorectal cancer?

Conclusion

The addition of natural beta-interferon did not improve the therapeutic outcome compared to the original regimen.

Supporting Evidence

  • Five complete responses and 17 partial responses were observed, resulting in a 41% response rate.
  • The median time to treatment failure was 6.4 months.
  • The median duration of survival was 15.0 months.
  • Grade III-IV toxicity occurred in 18% of patients.
  • Previous adjuvant treatment influenced the clinical response, with a 10% response rate in those who had received it.

Takeaway

Doctors tested a new treatment for colon cancer that combined two types of chemotherapy. They found that adding a special protein didn't make it work better.

Methodology

Patients received alternating cycles of bolus 5-fluorouracil and continuous infusion 5-fluorouracil, with the addition of natural beta-interferon in the bolus phase.

Potential Biases

Potential bias due to the non-randomized design and differences in patient characteristics.

Limitations

The study was not randomized, and the patient population had different prognostic factors compared to previous studies.

Participant Demographics

{"median_age":63,"gender_distribution":{"male":32,"female":24},"performance_status":{"0":29,"1":22,"2":5},"primary_site":{"colon":43,"rectum":13},"previous_adjuvant_chemotherapy":10}

Statistical Information

P-Value

0.038

Confidence Interval

95% confidence limits, 28-55%

Statistical Significance

p=0.038

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication